Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 192

1.

Circulating microRNAs in patients with chronic hepatitis C and non-alcoholic fatty liver disease.

Cermelli S, Ruggieri A, Marrero JA, Ioannou GN, Beretta L.

PLoS One. 2011;6(8):e23937. doi: 10.1371/journal.pone.0023937.

2.

Association of Circulating Serum miR-34a and miR-122 with Dyslipidemia among Patients with Non-Alcoholic Fatty Liver Disease.

Salvoza NC, Klinzing DC, Gopez-Cervantes J, Baclig MO.

PLoS One. 2016 Apr 14;11(4):e0153497. doi: 10.1371/journal.pone.0153497.

3.

Associations between circulating microRNAs (miR-21, miR-34a, miR-122 and miR-451) and non-alcoholic fatty liver.

Yamada H, Suzuki K, Ichino N, Ando Y, Sawada A, Osakabe K, Sugimoto K, Ohashi K, Teradaira R, Inoue T, Hamajima N, Hashimoto S.

Clin Chim Acta. 2013 Sep 23;424:99-103. doi: 10.1016/j.cca.2013.05.021.

PMID:
23727030
4.

Elevated miR-33a and miR-224 in steatotic chronic hepatitis C liver biopsies.

Lendvai G, Jármay K, Karácsony G, Halász T, Kovalszky I, Baghy K, Wittmann T, Schaff Z, Kiss A.

World J Gastroenterol. 2014 Nov 7;20(41):15343-50. doi: 10.3748/wjg.v20.i41.15343.

5.

Plasma microRNAs are sensitive indicators of inter-strain differences in the severity of liver injury induced in mice by a choline- and folate-deficient diet.

Tryndyak VP, Latendresse JR, Montgomery B, Ross SA, Beland FA, Rusyn I, Pogribny IP.

Toxicol Appl Pharmacol. 2012 Jul 1;262(1):52-9. doi: 10.1016/j.taap.2012.04.018.

6.

Disease-specific miR-34a as diagnostic marker of non-alcoholic steatohepatitis in a Chinese population.

Liu XL, Pan Q, Zhang RN, Shen F, Yan SY, Sun C, Xu ZJ, Chen YW, Fan JG.

World J Gastroenterol. 2016 Nov 28;22(44):9844-9852.

7.

MicroRNA-122 associates with serum apolipoprotein B but not liver fibrosis markers in CHC genotype 1 infection.

Lee TH, Matta B, King BD, Hodges MR, Tillmann HL, Patel K.

J Med Virol. 2015 Oct;87(10):1722-6. doi: 10.1002/jmv.24230.

PMID:
25963774
8.

Circulating microRNA signature in non-alcoholic fatty liver disease: from serum non-coding RNAs to liver histology and disease pathogenesis.

Pirola CJ, Fernández Gianotti T, Castaño GO, Mallardi P, San Martino J, Mora Gonzalez Lopez Ledesma M, Flichman D, Mirshahi F, Sanyal AJ, Sookoian S.

Gut. 2015 May;64(5):800-12. doi: 10.1136/gutjnl-2014-306996.

9.

Circulating microparticles as disease-specific biomarkers of severity of inflammation in patients with hepatitis C or nonalcoholic steatohepatitis.

Kornek M, Lynch M, Mehta SH, Lai M, Exley M, Afdhal NH, Schuppan D.

Gastroenterology. 2012 Aug;143(2):448-58. doi: 10.1053/j.gastro.2012.04.031.

10.

miR-34a/SIRT1/p53 is suppressed by ursodeoxycholic acid in the rat liver and activated by disease severity in human non-alcoholic fatty liver disease.

Castro RE, Ferreira DM, Afonso MB, Borralho PM, Machado MV, Cortez-Pinto H, Rodrigues CM.

J Hepatol. 2013 Jan;58(1):119-25. doi: 10.1016/j.jhep.2012.08.008.

PMID:
22902550
11.

Up-regulation of circulating miR-20a is correlated with hepatitis C virus-mediated liver disease progression.

Shrivastava S, Petrone J, Steele R, Lauer GM, Di Bisceglie AM, Ray RB.

Hepatology. 2013 Sep;58(3):863-71. doi: 10.1002/hep.26296.

12.

Serum acid sphingomyelinase is upregulated in chronic hepatitis C infection and non alcoholic fatty liver disease.

Grammatikos G, Mühle C, Ferreiros N, Schroeter S, Bogdanou D, Schwalm S, Hintereder G, Kornhuber J, Zeuzem S, Sarrazin C, Pfeilschifter J.

Biochim Biophys Acta. 2014 Jul;1841(7):1012-20. doi: 10.1016/j.bbalip.2014.04.007.

PMID:
24769340
13.

Parallel expression profiling of hepatic and serum microRNA-122 associated with clinical features and treatment responses in chronic hepatitis C patients.

Butt AM, Raja AJ, Siddique S, Khan JS, Shahid M, Tayyab GU, Minhas Z, Umar M, Idrees M, Tong Y.

Sci Rep. 2016 Feb 22;6:21510. doi: 10.1038/srep21510.

14.

Prevalence of steatosis and insulin resistance in patients with chronic hepatitis B compared with chronic hepatitis C and non-alcoholic fatty liver disease.

Pais R, Rusu E, Zilisteanu D, Circiumaru A, Micu L, Voiculescu M, Poynard T, Ratziu V.

Eur J Intern Med. 2015 Jan;26(1):30-6. doi: 10.1016/j.ejim.2014.12.001.

PMID:
25553983
15.

Increased soluble CD36 is linked to advanced steatosis in nonalcoholic fatty liver disease.

García-Monzón C, Lo Iacono O, Crespo J, Romero-Gómez M, García-Samaniego J, Fernández-Bermejo M, Domínguez-Díez A, Rodríguez de Cía J, Sáez A, Porrero JL, Vargas-Castrillón J, Chávez-Jiménez E, Soto-Fernández S, Díaz A, Gallego-Durán R, Madejón A, Miquilena-Colina ME.

Eur J Clin Invest. 2014 Jan;44(1):65-73. doi: 10.1111/eci.12192.

PMID:
24134687
16.

Serum MicroRNAs as Potential Biomarkers for Early Diagnosis of Hepatitis C Virus-Related Hepatocellular Carcinoma in Egyptian Patients.

Motawi TK, Shaker OG, El-Maraghy SA, Senousy MA.

PLoS One. 2015 Sep 9;10(9):e0137706. doi: 10.1371/journal.pone.0137706.

17.

Hepatic and serum levels of miR-122 after chronic HCV-induced fibrosis.

Trebicka J, Anadol E, Elfimova N, Strack I, Roggendorf M, Viazov S, Wedemeyer I, Drebber U, Rockstroh J, Sauerbruch T, Dienes HP, Odenthal M.

J Hepatol. 2013 Feb;58(2):234-9. doi: 10.1016/j.jhep.2012.10.015.

PMID:
23085648
18.

Obesity and steatosis influence serum and hepatic inflammatory markers in chronic hepatitis C.

Jonsson JR, Barrie HD, O'Rourke P, Clouston AD, Powell EE.

Hepatology. 2008 Jul;48(1):80-7. doi: 10.1002/hep.22311.

PMID:
18571785
19.

Longitudinal study of circulating miR-122 in a rat model of non-alcoholic fatty liver disease.

Yamada H, Ohashi K, Suzuki K, Munetsuna E, Ando Y, Yamazaki M, Ishikawa H, Ichino N, Teradaira R, Hashimoto S.

Clin Chim Acta. 2015 Jun 15;446:267-71. doi: 10.1016/j.cca.2015.05.002.

PMID:
25958847
20.

Serum microRNA-21 as marker for necroinflammation in hepatitis C patients with and without hepatocellular carcinoma.

Bihrer V, Waidmann O, Friedrich-Rust M, Forestier N, Susser S, Haupenthal J, Welker M, Shi Y, Peveling-Oberhag J, Polta A, von Wagner M, Radeke HH, Sarrazin C, Trojan J, Zeuzem S, Kronenberger B, Piiper A.

PLoS One. 2011;6(10):e26971. doi: 10.1371/journal.pone.0026971.

Items per page

Supplemental Content

Support Center